Cargando…

Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a highly malignant tumor with poor prognosis and high mortality. There is a dearth of effective early diagnostic tools, so liver resection surgery and liver transplantation are the only effective medical treatments. The most commonly used marker for HCC detection is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Chang-Yi, Chen, Shih-Ya, Peng, Hui-Ling, Kan, Pu-Yeh, Chang, Wan-Chi, Yen, Chia-Jui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351641/ https://www.ncbi.nlm.nih.gov/pubmed/28031532 http://dx.doi.org/10.18632/oncotarget.14115

Ejemplares similares

KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma
por: Li, Wen-Chao, et al.
Publicado: (2019)

Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma
por: Mínguez, Beatriz, et al.
Publicado: (2011)

Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma(☆)
por: Shih, Tsung-Chieh, et al.
Publicado: (2020)

RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma
por: Zheng, Wangyang, et al.
Publicado: (2022)

S100 Proteins as Diagnostic and Prognostic Markers in Colorectal and Hepatocellular Carcinoma
por: Maletzki, Claudia, et al.
Publicado: (2012)

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
por: Liang, Hao, et al.
Publicado: (2021)

Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma
por: Luo, Biyuan, et al.
Publicado: (2022)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Sorafenib treatment on Chinese patients with advanced hepatocellular carcinoma: A study on prognostic factors of the viral and tumor status
por: Lee, Shou-Wu, et al.
Publicado: (2019)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma
por: Chang, Xian, et al.
Publicado: (2021)

DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma
por: Li, Qun, et al.
Publicado: (2017)

Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma
por: Wu, Xiaochang, et al.
Publicado: (2022)

Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study
por: Chang, Chun-Chi, et al.
Publicado: (2018)

Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
por: Kim, Yong-June, et al.
Publicado: (2016)

Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers
por: Ho, Ai-Sheng, et al.
Publicado: (2014)

Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma
por: Liu, Kun, et al.
Publicado: (2016)

Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2015)

Predict Early Recurrence of Resectable Hepatocellular Carcinoma Using Multi-Dimensional Artificial Intelligence Analysis of Liver Fibrosis
por: Liu, I-Ting, et al.
Publicado: (2021)

DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

TPX2 Is a Prognostic Marker and Contributes to Growth and Metastasis of Human Hepatocellular Carcinoma
por: Huang, Yuqi, et al.
Publicado: (2014)

Validation and Comparison of the 7(th) Edition of the American Joint Committee on Cancer Staging System and Other Prognostic Models to Predict Relapse-Free Survival in Asian Patients with Parotid Cancer
por: Lu, Chang-Hsien, et al.
Publicado: (2016)

Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer
por: Wan, Xuechao, et al.
Publicado: (2016)

Comprehensive Analysis of HOX Family Members as Novel Diagnostic and Prognostic Markers for Hepatocellular Carcinoma
por: Jin, Zhipeng, et al.
Publicado: (2022)

Common Sensitive Diagnostic and Prognostic Markers in Hepatocellular Carcinoma and Their Clinical Significance: A Review
por: Samman, Basim Saleh, et al.
Publicado: (2022)

Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer
por: Chang, Pei-Hung, et al.
Publicado: (2017)

Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma
por: Wu, Jia-Feng, et al.
Publicado: (2017)

Progress on diagnostic and prognostic markers of pancreatic cancer
por: YANG, HONG, et al.
Publicado: (2023)

Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study
por: Lewin, Jörn, et al.
Publicado: (2021)

Lin28B Is an Oncofetal Circulating Cancer Stem Cell-Like Marker Associated with Recurrence of Hepatocellular Carcinoma
por: Cheng, Shu-Wen, et al.
Publicado: (2013)

Identification of Postoperative Prognostic MicroRNA Predictors in Hepatocellular Carcinoma
por: Huang, Ya-Hui, et al.
Publicado: (2012)

Methylation-Driven Gene PLAU as a Potential Prognostic Marker for Differential Thyroid Carcinoma
por: Wu, Min, et al.
Publicado: (2022)

Diagnostic and Prognostic Value of Talin-1 and Midkine as Tumor Markers in Hepatocellular Carcinoma in Egyptian Patients
por: Mashaly, Aya H, et al.
Publicado: (2018)

CENPO is Associated with Immune Cell Infiltration and is a Potential Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: He, Kun, et al.
Publicado: (2022)

Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma
por: Tsai, Hung-Wen, et al.
Publicado: (2018)

Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer
por: Skrypkina, Inessa, et al.
Publicado: (2016)

Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma
por: Tian, Xiao-Peng, et al.
Publicado: (2023)

Diagnostic and Prognostic Values of MANF Expression in Hepatocellular Carcinoma
por: He, Jingyi, et al.
Publicado: (2020)

Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors
por: Sun, Li-Yue, et al.
Publicado: (2021)

Prognostic analysis and validation of diagnostic marker genes in patients with osteoporosis
por: Wang, Xing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u20ucmqvg7c6peeqrbkm7ft16h